West Pharmaceutical Services, Inc. (BMV:WST)
Mexico · Delayed Price · Currency is MXN 4,435.00
0.00 (0.00%)
At close: Sep 23, 2025
BMV:WST Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 487.7 | 492.7 | 593.4 | 585.9 | 661.8 | 346.2 | Upgrade |
Depreciation & Amortization | 162.3 | 155.4 | 137.3 | 120.6 | 122.3 | 109.1 | Upgrade |
Stock-Based Compensation | 18.1 | 18.7 | 23.3 | 23.7 | 37.5 | 34 | Upgrade |
Other Adjustments | 6.5 | -16.3 | 42.9 | 8.8 | -39.5 | -6.5 | Upgrade |
Change in Receivables | - | -58.8 | 4 | -35.6 | -123.5 | -46.6 | Upgrade |
Changes in Inventories | - | 42 | -13.5 | -49.8 | -86.5 | -73.7 | Upgrade |
Changes in Accounts Payable | - | 2.9 | 4.4 | -2.8 | 16.8 | 36.6 | Upgrade |
Changes in Other Operating Activities | - | 16.8 | -15.3 | 73.2 | -4.9 | 73.4 | Upgrade |
Operating Cash Flow | 676.7 | 653.4 | 776.5 | 724 | 584 | 472.5 | Upgrade |
Operating Cash Flow Growth | -10.06% | -15.85% | 7.25% | 23.97% | 23.60% | 28.68% | Upgrade |
Capital Expenditures | -332.7 | -377 | -362 | -284.6 | -253.4 | -174.4 | Upgrade |
Payments for Business Acquisitions | - | - | - | - | -2.2 | - | Upgrade |
Other Investing Activities | - | -1.7 | -6.7 | -3.6 | 2.5 | -5.1 | Upgrade |
Investing Cash Flow | -333.4 | -378.7 | -368.7 | -288.2 | -253.1 | -179.5 | Upgrade |
Long-Term Debt Issued | - | 164.7 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | -0.9 | -192.3 | -2.4 | -44.3 | -2.2 | -2.3 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -0.9 | -27.6 | -2.4 | -44.3 | -2.2 | -2.3 | Upgrade |
Issuance of Common Stock | 18.7 | 32.7 | 51 | 28.2 | 37.1 | 34.7 | Upgrade |
Repurchase of Common Stock | -240.8 | -566.6 | -451.2 | -222.2 | -151.9 | -121.4 | Upgrade |
Net Common Stock Issued (Repurchased) | -222.1 | -533.9 | -400.2 | -194 | -114.8 | -86.7 | Upgrade |
Common Dividends Paid | -60.1 | -59.1 | -57 | -54.1 | -51.1 | -48.1 | Upgrade |
Other Financing Activities | - | -2 | - | -1.2 | - | - | Upgrade |
Financing Cash Flow | -295.2 | -622.6 | -459.6 | -293.6 | -168.1 | -137.1 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 15.4 | -21.4 | 11.4 | -10.5 | -15.7 | 20.5 | Upgrade |
Net Cash Flow | 63.5 | -369.3 | -40.4 | 131.7 | 147.2 | 176.4 | Upgrade |
Beginning Cash & Cash Equivalents | 446.2 | 853.9 | 894.3 | 762.6 | 615.5 | 439.1 | Upgrade |
Ending Cash & Cash Equivalents | 509.7 | 484.6 | 853.9 | 894.3 | 762.6 | 615.5 | Upgrade |
Free Cash Flow | 344 | 276.4 | 414.5 | 439.4 | 330.6 | 298.1 | Upgrade |
Free Cash Flow Growth | 24.46% | -33.32% | -5.67% | 32.91% | 10.90% | 23.80% | Upgrade |
FCF Margin | 11.62% | 9.55% | 14.05% | 15.22% | 11.68% | 13.89% | Upgrade |
Free Cash Flow Per Share | 4.71 | 3.75 | 5.50 | 5.80 | 4.33 | 3.93 | Upgrade |
Levered Free Cash Flow | 316.8 | 305.2 | 341.9 | 398.2 | 453.9 | 314.9 | Upgrade |
Unlevered Free Cash Flow | 290.95 | 305.36 | 308.45 | 466.77 | 438.91 | 304.39 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.